RXRX R&D Expense Growth
Recursion Pharmaceuticals Inc Clas · R&D Expense Growth
RXRX R&D Expense Growth
Latest reported35.25%period ending
RXRX FY R&D Growth (YoY) (0.00% → 35.25%)
Latest values, visible window
High-resolution chart · PNG
RXRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 35.255% | |
| 30.3429% | |
| 54.934% | |
| 15.0993% | |
| 113.6341% | |
| 38.2239% | |
| 0% |